- Home
- TLX vs ALHC Comparison
TLX vs ALHC Comparison
Compare TLX & ALHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- ALHC
- Stock Information
- Founded
- TLX 2015
- ALHC 2013
- Country
- TLX Australia
- ALHC United States
- Employees
- TLX N/A
- ALHC N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- ALHC Medical Specialities
- Sector
- TLX Health Care
- ALHC Health Care
- Exchange
- TLX Nasdaq
- ALHC Nasdaq
- Market Cap
- TLX 3.2B
- ALHC 2.7B
- IPO Year
- TLX N/A
- ALHC 2021
- Fundamental
- Price
- TLX $10.07
- ALHC $17.60
- Analyst Decision
- TLX Strong Buy
- ALHC Buy
- Analyst Count
- TLX 4
- ALHC 11
- Target Price
- TLX $21.00
- ALHC $18.14
- AVG Volume (30 Days)
- TLX 190.7K
- ALHC 4.4M
- Earning Date
- TLX 01-01-0001
- ALHC 10-30-2025
- Dividend Yield
- TLX N/A
- ALHC N/A
- EPS Growth
- TLX N/A
- ALHC N/A
- EPS
- TLX 0.04
- ALHC N/A
- Revenue
- TLX $664,225,558.00
- ALHC $3,335,894,000.00
- Revenue This Year
- TLX N/A
- ALHC $47.18
- Revenue Next Year
- TLX N/A
- ALHC $28.47
- P/E Ratio
- TLX $240.12
- ALHC N/A
- Revenue Growth
- TLX 55.35
- ALHC 49.46
- 52 Week Low
- TLX $8.93
- ALHC $10.11
- 52 Week High
- TLX $30.36
- ALHC $21.06
- Technical
- Relative Strength Index (RSI)
- TLX 47.62
- ALHC 62.13
- Support Level
- TLX $9.94
- ALHC $17.00
- Resistance Level
- TLX $10.28
- ALHC $17.69
- Average True Range (ATR)
- TLX 0.22
- ALHC 0.66
- MACD
- TLX 0.11
- ALHC -0.04
- Stochastic Oscillator
- TLX 33.12
- ALHC 90.61
About TLX Telix Pharmaceuticals Limited American Depositary Shares
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
About ALHC Alignment Healthcare Inc.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.